Associate Principal Scientist, Research Pharmacy
Merck & Co., Inc.
Dr. Iriny Ekladious is an Associate Principal Scientist in Sterile and Specialty Products within the Pharmaceutical Sciences organization at Merck. In her current role, she supports the formulation and process development of sterile drug products across small molecules and biologics, and spanning multiple dosage forms and images, including solution-in-vial and drug-device combination products.
Iriny joined Merck in 2018 as a member of the Discovery Pharmaceutical Sciences group, in which she facilitated the translation of robust preclinical drug candidates from discovery to development by assessing their physicochemical attributes and liabilities. During her time in discovery, Iriny evaluated the developability of various modalities including small molecules, peptides, and biologics.
Prior to joining Merck, Iriny completed her graduate training in Biomedical Engineering at Boston University, under the mentorship of Professor Mark Grinstaff. She was an NSF Graduate Research Fellow and completed her degree with joint training in Biomolecular Pharmacology from the Boston University School of Medicine. Iriny’s research focused on the rational design and development of novel polymeric nanocarriers for the controlled delivery of chemotherapeutics. Iriny obtained her BS in Biological Engineering from Cornell University.